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Abstract
The goal of this study was to determine whether the dopamine D3 receptor in limbic structures plays a role in the shell-specific and 
dopamine-dependent display of turning behaviour in rats. When combined with the dopamine receptor agonist (±  )-i-phenyl-2,3,4,5- 
tetrahydro-1 //-3-benzazepine-7,8-diol (SKF-38393, 5 jx g ) ,  the putative dopamine D3 receptor agonist (±)-7-hydroxy-/V,N-di-n-propyl-2- 
aminotetralin (7-OH-DPAT, 1, 5 and 10 jJLg) elicited contralateral turning in a dose-dependent manner following unilateral injection into 
the shell, but not the core, of the nucleus accumbens. The turning pattern displayed was identical to that reported previously after 
intra-accumbens administration of the cocktail of SKF-38393 and the dopamine D2 receptor agonist quinpirole. The behaviour under 
study was dose-dependently attenuated by local administration of the dopamine Dj receptor antagonist /?(-h)-7-chloro-8-hydroxy-3- 
methyl-1-phenyl-2,3,4,5-tetrahydro-1//-3-benzazepi ne (SCH 23390: 10 and 100 ng), the dopamine D2 receptor antagonist domperidone 
(25 and 50 ng) or the dopamine D2/3 receptor antagonist /-sulpiride (5 and 25 ng). Combined blockade of both dopamine Dj and D2 
receptors in the shell with a dose of either antagonist alone that produced just a moderate reduction (10 ng SCH 23390 and 50 ng 
domperidone) completely antagonized the turning behaviour elicited by the cocktail of SKF-38393 and 7-OH-DPAT. Replacing 
7-OH-DPAT by another putative dopamine D3 receptor agonist, 5( + )-(4a/?,10W?)-3,4,4tf,10£~tetrahydro-4-propyl-2tf,5//-[l]benzo- 
pyrano[4,3-6]-l,4-oxazin-9-ol (PD 128,907, 10 jxg), in the cocktail did produce no turning behaviour at all. It is concluded that 
mesolimbic dopamine D3 receptors play no role in the dopamine-dependent and shell-specific turning behaviour: the contribution of 
7-OH-DPAT in the cocktail of SKF-38393 and 7-OH-DPAT to the display of turning behaviour is solely due to its ability to activate 
dopamine D2 receptors,
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1. Introduction
7-OH-DPAT ( (±  )-7-hydroxy-N,N-di-«-propyl“2-amino 
tetralin) has been found to act as a selective agonist at 
dopamine D^ receptors in a variety of studies (biochemical 
studies: Rivet et al., 1994; Sokoloff et al., 1990; electro- 
physiological studies: Kreiss et al., 1995; behavioural stud­
ies: Daly and Waddington, 1993; Damsma et al., 1993; 
Svensson et al., 1994; Waters et alM 1993). However, later 
studies have demonstrated that 7-OH-DPAT may be less 
selective than originally claimed (biochemical studies: 
Gonzalez and Sibley, 1995; electrophysiological studies:
Corresponding author. Fax: 81 3 3219-8136.
Freedman et al., 1994; Liu et al., 1994; behavioural stud­
ies: Koshikawa et al., 1996b; Large and Stubbs, 1994). 
Apart from the accompanying paper, in which the effects 
of intra-accumbens injections of 7-OH-DPAT on jaw 
movements were studied (Koshikawa et al., 1996b), all 
remaining studies on the behavioural function of dopamine 
D3 receptors are limited to studies in which 7-OH-DPAT 
and other putative, selective dopamine D3 receptor agents 
are systemically applied. Dopamine D3 receptors are abun­
dantly concentrated in limbic structures, such as the nu­
cleus accumbens (Bouthenet et al., 1991; Levesque et al., 
1992), and evidence has been presented that a subpopula­
tion of dopamine D3 receptors is located on neurons which 
serve as a major output route of the shell, but not the core, 
of the nucleus (Diaz et al., 1995). In our accompanying
0014-2999/96/$ 15.00 Copyright © 1996 Elsevier Science B.V. All rights reserved. 
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paper we provide evidence that the contribution of 7-OH- 
DPAT in the cocktail of SKF-82958 ((±)-6-chloro-7,8-di~
hydroxy-3-allyl-l-phenyl-2,3,4,5-tetrahydro-1 //-3-benzaze-
pine) and 7-OH-DPAT to the display of jaw  movements is 
solely due to its ability to activate dopamine D2 receptors. 
Moreover, we provide evidence that mesoliinbic dopamine 
D3 receptors play no role in dopamine-dependent and 
shell-specific jaw movements. Given these findings, the 
question arose whether the same holds true for other 
dopamine-specific and shell-specific behaviours.
We have recently shown that unilateral administration 
of a highly specific dose combination of the dopamine 
receptor agonist ( ± )- 1-phenyl-2,3,4,5-tetrahydn> 1 //-3- 
benzazepine-7,8-diol (SKF-38393, 5 fxg) and the dopamine 
D2 receptor agonist quinpirole (10 fxg) into the shell, but 
not the core, of the nucleus accumbens is required for the 
elicitation of a highly characteristic turning behaviour in 
rats. Since this behaviour is inhibited by the intra-accu­
mbens administration of either the dopamine receptor 
antagonist R( +  )-7-chIoro-8-hydroxy-3-methyl-1 -phenyl- 
2, 3,4,5-tetrahydro-l //-3-benzazepine (SCH 23390) or the 
dopamine D 2 receptor antagonist /-sulpiride (Cools et al., 
1995; Koshikawa et al., 1996a), it has been suggested that 
dopamine Dj and D 2 receptors play a role in the expres­
sion of these behaviours. However, a role of dopamine D3 
receptors could not be excluded; quinpirole has a high 
affinity not only at the dopamine D 2 receptor (Stoof and 
Kebabian, 1981), but also at the dopamine D 3 receptor 
(Sokoloff et al., 1990), and /-sulpiride has only a marginal 
lower affinity at the dopamine D 3 receptor than at the 
dopamine D2 receptor (Sokoloff et al., 1990). Accord­
ingly, we investigated the behavioural role of dopamine D3 
receptors in dopamine-dependent and shell-specific turn­
ing. For that purpose, we replaced quinpirole in the SKF- 
38393-quinpirole cocktail by the putative dopamine D3 
receptor agonist 7-OH-DPAT and studied the effects of 
intra-accumbens administration of this cocktail upon turn­
ing behaviour.
Given the lack of available dopamine D 3 receptor an­
tagonists at the moment, the following strategy was used to 
assess the specificity of the effects elicited. First, the 
effects following administration of the cocktail into the 
shell were compared with those following its administra­
tion into the core, an area containing far less dopamine 
receptors than the shell. Second, we investigated to what 
extent the effects elicited by this cocktail could be antago­
nized by the dopamine Dj receptor antagonist SCH 23390, 
the dopamine D2 receptor antagonist domperidone or the 
dopamine D 2/,3 receptor antagonist /-sulpiride. Third, the 
effect of a mixture of SCH 23390 and domperidone upon 
the effects elicited by the cocktail was analysed. Finally, 
the effect of the cocktail was compared to that of a 
cocktail, in which 7-OH-DPAT was replaced by another 
putative dopamine D 3 receptor agonist, viz. 5( +  )-(4a/?t 
10 W?)-3,4,4 a , 10 />tetrahydro-4-propyl-2 f/,5  /ƒ-[ 1 ]benzo- 
pyrano[4,3-i?]-l,4-oxazin-9-ol (PD 128,907). The binding
profile of PD 128,907 for dopamine D, receptors relative 
to dopamine D2 receptors is reported to be more selective 
(54-fold) than that of 7-OH-DPAT (7-fold) (Sautel et al., 
1995).
2. M aterials and methods
2J. Surgical procedures
Male Wistar rats weighing 200-250 g were used 
throughout the experiments. They were housed in a tem­
perature-controlled environment and under a light (07:00- 
19:00 h )/dark  (19:00-07:00 h) cycle with free access to 
food and water. Behavioural testing was performed be­
tween 10:00 h and 15:00 h. For stereotactic implantation of 
cannulas, the rats were anaesthetized with sodium pento­
barbitone (50 m g /k g  i.p.) and mounted in a stereotactic 
apparatus (Narishige, Japan). Guide cannulas (0.5 mm o.dM 
0.3 mm i.d., 6.0 mm length) were implanted into the shell 
or into the core of the nucleus accumbens according to 
previously described procedures (Prinssen et al., 1994; 
Koshikawa et al., 1996a). The coordinates based on the 
atlas of Paxinos and Watson (1986) were: anterior = 10.6 
mm, vertical = 8.0 mm, lateral =  0.5 mm (shell); anterior 
= 10.6 mm, vertical =  7.0 mm, lateral — 1.2 mm (core). 
The cannulas directed at the shell were angled 21°, and 
cannulas directed at the core were angled 18° from the 
mid-sagittal plane to avoid the ventricular system. Damage 
to the target site was minimized by implanting the tips of 
the guide cannulas 1.2 mm (for the core) or 2.0 mm (for 
the shell) above the desired injection site. Wire stylets 
were placed in the guide cannulas to prevent occlusion. 
The animals were allowed at least 1 week post-operative 
recovery before behavioural testing and were used only 
once. All experiments were performed according to institu­
tional and national guideline of animal experimentation.
2.2. Intracerebral microinjection and drugs
The animals (n  = 6 -10  per experiment) received unilat­
eral injection of the dopamine D| receptor agonist SKF- 
38393 (5 |xg; ( ±)-l-phenyl-2,3,4,5-tetrahydro-1 Z/-3-bc- 
nzazepine-7,8-diol hydrochloride; Research Biochemicals 
International), the putative dopamine D3 receptor agonist 
7-OH-DPAT ( l ,  5 or 10 jxg; ( ± )-7-hydroxy-/V,/V-dwi-pro- 
pyl-2-aminotetralin hydrobromide; Research Biochemicals 
International) or their combination (cocktail). In a separate 
set of experiments another putative dopamine D^ receptor
agonist PD 128,907 (10 fig; S( + )-(4«/U0W ?)- 
3,4,4 rt, 10/>tetrahy dro-4-propy 1-2 /7,5 /•/-[ 1 ]ben/.opy rano[4, 
3-/;]-l,4-oxazin-9-ol hydrochloride; Research Biochemi­
cals International) was tested. Control animals received the 
solvent of the drugs. In additional sets of experiments the 
dopamine D } receptor antagonist SCH 23390 (10, 100 or 
500 ng; R( -f )-7-chloro-8-hydroxy-3-methyl-1 -phenyl-
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2 ,3 ,4 ,5 -tetrahydro-l tf-3-benzazepine hydrochloride; Re­
search Biochemicals International) and /o r the dopamine 
D2 receptor antagonist domperidone (25, 50 or 100 ng; 
Research Biochemicals International), or the dopamine 
D2 / 3 receptor antagonist /-sulpiride (5, 25 or 50 ng; 
Ravizza) were given into the shell 10 min prior to the 
agonists injection. Domperidone and /-sulpiride were dis­
solved in a few drops of diluted acetic acid and then 
diluted with saline (0.9% w /v  NaCl solution) for injec­
tion. All remaining drugs were dissolved in saline immedi­
ately before use. For the unilateral intracerebral micro­
injection, the rat was held manually while the stylet was 
removed and the injection needle (31 gauge) was lowered 
through the guide cannula until it protruded 1.2 mm (core) 
or 2.0 mm (shell) beyond the tip. The needle was con­
nected to a Hamilton syringe and the injection was made
5-min periods for 90-120 min, starting immediately after 
the injection.
2.4. Histology
At the end of each experiment, the rats were deeply 
anaesthetized with sodium pentobarbitone and perfused 
transcardially with 10% of formalin. The brains were 
removed, sectioned (50 (im) and stained with Cresyl violet 
to visualize the injection site.
2.5. Data analysis
All values are expressed as means ±  S.E.M. and anal­
ysed using either one-way analysis of variance (ANOVA) 
or two-way ANOVA (group X time) followed by a post-hoc
slowly in a volume of 0.5 fxl over 30 s, alter which the Newman-Keuls test, where appropriate. Differences were 
needle was left in place for a further 30 s. Doses and time considered significant when P <  0.05, 
schedule were based on previous studies (Saigusa et al.,
1993, 1995; Cools et a l, 1995; Koshikawa et al., 1996a).
3. Results
2.3. Behavioural methods
The rats were placed individually in a circular chamber 
(60 cm diameter) with 30-cm high Perspex sides at least 1 
h before the start of the experiment. To allow detailed 
observation of the turning behaviour, limb stepping pat­
terns and spinal curvature, a mirror was mounted under­
neath the chamber at an angle of 30° and the image was 
recorded on videotape for off-line analysis. Contralateral 
and ipsilateral turnings (defined as complete 360° turns) 
were counted visually by a trained observer who had no 
prior knowledge of the drug treatment. Description of the 
stepping pattern involved analysis of the presence/absence 
of the following items: ( l)  lateral head movements, de­
fined as lateral movements of the head in relation to the 
upper torso; (2) lateral torso movements, defined as lateral 
movements of the upper torso in relation to the lower 
torso; (3) lateral pelvic movements, defined as lateral 
movements of the lower torso in relation to the hindquar­
ters; (4) normal hindlimb stepping during turning, charac­
terized by the sequential occurrence of two forward steps 
(hindlimb forward steps: Cools and Jongen-Relo, 1991); 
(5) apomorphine-induced hindlimb stepping, characterized 
by the sequential occurrence of a closing and an open step 
(hindlimb doublet: Cools and Jongen-Relo, 1991); (6) 
normal forelimb stepping during turning, characterized by 
the sequential occurrence of a closing and an open step 
(forelimb doublet: Cools and Jongen-Relo, 1991); (7) dex- 
amphetamine-induced forelimb stepping, characterized by 
the sequential occurrence of a crossing and an open step 
(forelimb crossing step: Cools and Jongen-Relo, 1991); (8) 
pivoting, characterized by turning around one leg (Szecht- 
man et al., 1985); (9) uncoupling of lateral movements of 
the torso and the limbs, causing the legs to lag behind 
(dragging). Observations were made during consecutive
3.1. Effects of combined injection o f  SKF-38393 and 7- 
OH-DPAT into the core and the shell o f  the nucleus 
accumhens
Fig. 1 gives a survey of the core and shell region in 
which the injection sites were located; data of rats with 
injection sites outside the region were discarded in the 
analysis (n =  49).
When combined with SKF-38393 (5 |ig ) unilateral 
injections of 7-OH-DPAT (1 |xg, n =  6; 5 jig, n =  10; 10 
¡jig, n =  9) into the shell of the nucleus accumbens dose- 
dependently elicited contralateral turnings (Fig, 2), viz. 
turning directed away from the injection site in all tested 
rats. Ipsilateral turning rarely occurred (data not shown). 
When given alone, SKF-38393 (5 jxg, n — 6) and 7-OH-
Shell Core
10.6
Fig. 1. AU injection sites found in the shell (left) and the core (right) of 
the nucleus accumbens. Planes are modified to a series of 2 or 3 sections 
for each brain area from the atlas of Paxinos and Watson (1986); 
approximate coordinates indicated are in mm anterior to the interaural 
line.
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Fig. 2. Effects of unilateral injection of a combination of 7-OH-DPAT (I 
jjig • ,  5 jjug O or 10 p,g ■ )  and SKF-38393 (5 jxg) into the shell of the 
nucleus accumbens on production of contraversive turning. The data are 
expressed as the mean number of turns occurring in 5-min observation 
periods (n =  6-10). Vertical bars indicate S.E.M.
DPAT (10 jig, n = 6) remained ineffective following in­
jections into the shell: the number of turns in the SKF- 
38393-treated and the 7-OH-DPAT-treated rats, respec­
tively, did not significantly differ from that found in 
solvent-treated rats (n = 6). Comparing the effects of the 
combined treatment with the effects of each single drug 
resulted in a highly significant difference (overall F(3,23) 
=  21.42, P < 0.001; Newman-Keuls, P < 0.01 vs. SKF- 
38393, 7-OH-DPAT or solvent, respectively; Fig. 3, upper 
part).
In contrast, the combined administration of SKF-38393 
and 7-OH-DPAT (n =  9) was less effective when injected 
unilaterally into the core, although the effects were signifi­
cantly greater than those found after the administration of 
each drug alone or the solvent (overall F(3,23) = 3.36, 
P < 0.05; Newman-Keuls, P < 0.05 vs. SKF-38393 (n =  
6), 7-OH-DPAT (n =  6) or solvent (n =  6), respectively; 
Fig, 3, lower part).
Analysis of the stepping pattern induced by unilateral 
injections of the SKF-38393 and 7-OH-DPAT mixture into 
the shell showed that the rats displayed a characteristic 
stepping pattern that was highly comparable with that 
induced by unilateral injections of SKF-38393 and quinpi-
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Fig. 3. Effects of unilateral injection of saline, 5 jig SKF-38393, 10 jig 
7-OH-DPAT and the mixture of 5 jxg SKF-38393 and 10 |xg 7-OH-DPAT 
into the shell (upper part) and the core (lower part) of the nucleus 
accumbens (0.5 pJ) on production of contraversive turning. The data are 
expressed as the mean number of total turns occurring in a 120-min 
observation period after injection (n =  6-9). Vertical bars indicate S.E.M. 
* P < 0.05, ’ * P <  0.01.
role mixture into the nucleus (cf. Saigusa et al., 1993, 
1995; Koshikawa, 1994). In short, while turning around 
the contralateral hindlimb, the rats first made a tight 
contralateral turn by stepping backwards with the hindlimb 
followed by one step forwards with the ipsilateral hindlimb, 
then made another turn by stepping backwards with the 
contralateral hindlimb. Apart from the occurrence of a 
small number of forelimb crossing steps (Cools and Jon- 
gen-Relo, 1991), the rats displayed normal forelimb dou­
blets. Although no hindlimb doublets (Cools and Jongen- 
Relo, 1991) were seen, the ipsilateral hindlimb was 
dragged, while the animal was pivoting contralaterally
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Fig. 4. Effects of SCH 23390 (10 or 100 ng/0.5 A), domperidone (25 or 50 ng/0.5 jxl, B) and 1-sulpiride (5 or 25 ng/0.5 \lI  C) given 10 min prior to 
the mixture of SKF-38393 (5 ^g) and 7-OH-DPAT (10 jig): all injections were made into the shell of the nucleus accumbens. The data are expressed as 
the mean number of total turns occurring in a 120-min observation period ( n =  6-10). Vertical bars indicate S.E.M. Control «  effects of the mixture of 
SKF-38393 and 7-OH^DPAT. * P < 0.05, * ’ P < 0.01.
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around its contralateral hindlimb. The overall result was a 
severe head-to-tail curvature during turning and/or sitting.
3.2. Effects of SCH 23390, domperidone and l-sulpiride on 
turning elicited by the combined administration of SKF- 
38393 and 7-OH-DPAT into the shell
When given into the shell of the nucleus accumbens, 
SCH 23390 (10 and 100 ng; n = 6 in each group) dose-de- 
pendently suppressed the contralateral turning induced by 
unilateral injections of SKF-38393 (5 jxg) and 7-OH-DPAT 
(10 fig) mixture into the shell [saline pretreatment, 10 min 
before («  =  6) vs. 10 ng SCH 23390: H i , 10) = 5.26, 
P < 0.05, saline pretreatment vs. 100 ng SCH 23390: 
/*’(!, 10) =  16,48, P  < 0.003; Fig. 4A], A similar dose-de­
pendent inhibition was observed with domperidone (25 ng,
Hi,14) =  1.49, P =  0.24; 50 ng, H 1,14) =  5.55, P <
0.04; n — 6 in each group; Fig. 4B) and /-sulpiride (5 ng,
n 6, H i , 14) -  8.99, P <  0.01; 25 ng, n = 7, Hi,15)
14,62, P <  0.002; Fig. 4C): they all significantly reduced 
the response to the mixture, although this reduction re­
quired higher doses of domperidone than of /-sulpiride 
(Fig. 4B,C). Although higher doses of these antagonists 
were tested, their effects were not included in Fig. 4, since 
these doses produced a behavioural instead of pharmaco­
logical inhibition. So, 500 ng SCH 23390 affected the neck 
joint in some rats, preventing these rats from displaying 
normal forelimb stepping and pure contralateral head 
movements. When the head was moved laterally, the torso 
simultaneously moved laterally: the head appeared to be 
fixed to the torso. Consequently, these rats had difficulties 
with executing turning. Higher doses of both /-sulpiride 
(50 ng) and domperidone (100 ng) affected the mixture-in­
duced turning in a different manner. These drugs disturbed 
the hindlimb stepping; there was an uncoupling between 
lateral movements of the torso and those of the hindlimbs,
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Fig. 5. Effects of SCH 23390 (10 ng, • ) ,  domperidone (50 ng, O) or the 
mixture ( □ )  of SCH 23390 and domperidone given 10 min prior to the 
mixture of SKF-38393 (5 \ig) and 7-OH-DPAT (10 jJLg): all injections 
were made into the shell of the nucleus aecumbens (0.5 .^1). The data are 
expressed as the mean number of turns occurring in 5-min observation 
periods (/i =  6-10). Vertical bars indicate S.E.M. Control (■)=>* effects 
of the mixture of SKF-38393 and 7-OH-DPAT.
resulting in dragging of these limbs when the head and 
torso were completely rotated towards the contralateral 
side. Furthermore, the rats often had splayed hindlimbs. 
Overall, the highest doses of these drugs affected the 
turning by deficient hindlimb stepping.
3.3. Effects of combined injection o f  SCH 23390 and 
domperidone on turning elicited by administration o f  SKF- 
38393 and 7-OH-DPAT mixture into the shell
Simultaneous blockade of both dopamine Dj and D 2 
receptors in the shell of the nucleus accumbens, achieved 
by the focal injection of a mixture of doses of SCH 23390 
(10 ng) and domperidone (50 ng) which per se produced 
only a partial reduction, completely abolished the con­
tralateral turning induced by the SKF-38393 (5 pig) and 
7-OH-DPAT (10 |xg) mixture (Hi,  14) =  12.40, P <  
0,004; Fig. 5).
3.4. Effects o f  administration o f  the cocktail o f  SKF-38393 
and PD 128,907 into the shell
Injection of SKF-38393 (5 n-g) and the putative 
dopamine D3 receptor agonist PD 128,907 (10 fxg) into 
the shell of the nucleus accumbens remained ineffective. 
The total number of turns elicited during a 120-min obser­
vation period being 8.0 ±  9.4 (mean ±  S.E.M., n =  6); 
[ H M 0 )  =  4,7, P >  0.05] compared to 3.7 ±  0.3 after 
saline.
4. Discussion
The present study and the one reported in the accompa­
nying paper (Koshikawa et al„ 1996b) intended to provide 
evidence that dopamine D3 receptors play a role in mediat­
ing functions of mesolimbic structures as has been sug­
gested before (Diaz et al., 1995; Sokoloff et al., 1990). For 
that purpose, we focused our attention on a brain structure 
in which these receptors are abundantly concentrated, viz. 
the shell of the nucleus accumbens (Routhenet et aL, 1991; 
Diaz et al., 1995; Levesque et al., 1992) and chose two 
behaviours, viz. turning behaviour (present study) and jaw 
movements (accompanying paper: Koshikawa et alM 
1996b). These behaviours are known to be dopamine-de­
pendent and specific for the shell region of the nucleus 
accumbens (Cools et al., 1995; Koshikawa et al., 1996a). 
The present study on turning behaviour confirms and 
extends the conclusions put forward in our accompanying 
paper: the putative dopamine D 3 receptor agonist 7-OH- 
DPAT is rather a dopamine D 2 receptor agonist than a 
dopamine D3 receptor agonist, at least in our in vivo 
studies, and the dopamine D3 receptor is certainly not 
involved in the limbic functions under study. Below, the 
data giving rise to these conclusions concerning the turn­
ing behaviour are discussed.
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The present study shows that the cocktail of the putative 
dopamine D3 receptor agonist 7-OH-DPAT ( 1 , 5  and 10 
jjug) and the dopamine D : receptor agonist SKF-38393 (5 
(jig), like the cocktail of the dopamine D 2/3 receptor 
agonist quinpirole and the dopamine receptor agonist 
SKF-33393 (5 jxg) (Koshikawa et al., 1996a), elicited 
turning behaviour in a dose-dependent manner, when ad­
ministered unilaterally into the shell of the nucleus accum­
bens; administration of this combination into the core was 
far less effective. Comparison of the effects of the two 
cocktails with 7-OH-DPAT and quinpirole, respectively, 
reveals two phenomena: first, there was virtually no differ­
ence between the stepping patterns elicited by these cock­
tails; second, the peak of the time-response curve of the 
cocktail with 7-OH-DPAT appeared approximately 30 min 
earlier than that of the cocktail with quinpirole. Although 
these data are not yet sufficient to draw a definite conclu­
sion about the ability of 7-OH-DPAT to interact with 
dopamine D2 or D 3 receptors, the following data are 
conclusive in this respect. First, both the dopamine 
receptor antagonist (SCH 23390), the dopamine D2 recep­
tor antagonist domperidone and the dopamine D2/3 recep­
tor antagonist /-sulpiride dose-dependently attenuated the 
effects of the cocktail of SKF-38393 and 7-OH-DPAT. 
Second, combining a partially effective dose of the 
dopamine Dj receptor antagonist SCH 23390 (10 ng) with 
a partially effective dose of the dopamine D2 receptor 
antagonist domperidone (50 ng) completely inhibited the 
effects of the cocktail of SKF-38393 and 7-OH-DPAT. 
Third, combination of SKF-38393 and another putative 
dopamine D3 receptor agonist PD 128,907, which was 
reported to be far more selective for dopamine D3 recep­
tors than 7-OH-DPAT (Akunne et al., 1994; Sautel et al., 
1995), had no effect at all, when injected unilaterally into 
the shell in a dose (10 jmg) that 7-OH-DPAT was found 
highly effective.
All these data together give rise to two conclusions. 
First, the contribution of 7-OH-DPAT in the cocktail of 
SKF-38393 and 7-OH-DPAT to the display of turning 
behaviour is solely due to its ability to activate dopamine 
D2 receptors. This conclusion fits in with earlier reports 
showing that this drug behave similarly to dopamine D2 
receptor agonists (Caine et al., 1995; Freedman et al., 
1994; Gonzalez and Sibley, 1995; Large and Stubbs, 1994; 
Liu et al., 1994; Starr and Stair, 1995). The present study, 
however, shows that this holds also true for intracerebrally 
administered 7-OH-DPAT, confirming and extending 
thereby the findings reported in our accompanying paper 
(Koshikawa et al., 1996b). Second, the dopamine-depen­
dent and shell-specific turning behaviour is just mediated 
by stimulation of dopamine D { and D 2 receptors.
In summary, it was already known that 7-OH-DPAT 
behaves similarly to the dopamine D 2/3 receptor agonist 
quinpirole in various rodent paradigms (see above). Both 
the present study and the accompanying paper (Koshikawa 
et al., 1996b) provide direct evidence that the same holds
true for 7-OH-DPAT when its cifect on shell-specific 
behaviours, such as turning behaviour and jaw movements, 
are studied. All these data together show that a thorough 
réévaluation of the dopamine D3 receptor specificity of 
7-OH-DPAT is required. In addition, both the present 
study and the accompanying paper (Koshikawa ct al., 
1996b) provide direct evidence that mcsolimbic dopamine 
D^ receptors play no role in the dopamine-dependent and 
shell-specific turning behaviour and jaw movements, in 
other words, there is ample evidence that the mcsolimbic 
dopamine D3 receptors play no role in a series of well- 
known motor functions of limbic structures. Thus, the role 
of dopamine D3 receptors in mcsolimbic functions needs 
to await further investigations.
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